Cargando…

Important factors for the modelling and design of clinical trials for severe sepsis and multiple organ failure

Detalles Bibliográficos
Autores principales:	Shaikh, L, Stuart, H, Rhodes, A, Chang, RW, for the RIP Users Group
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301956/ http://dx.doi.org/10.1186/cc628

Ejemplares similares

Characteristics of patients with sepsis and multiple organ failure in the UK
por: Shaikh, L, et al.
Publicado: (1999)

Inclusion criteria in sepsis trials should include severity of organ dysfunction
por: Taneja, R, et al.
Publicado: (2001)

Multi-organ-failure (MOF) with and without sepsis: differences in incidence and pattern of detected arrhythmias
por: Prondzinsky, R, et al.
Publicado: (1997)

CVVH versus IHD in patients with multiple organ failure
por: Gašparović, V, et al.
Publicado: (2003)

Factors affecting mortality from acute renal failure in the ICU
por: Ostermann, ME, et al.
Publicado: (2002)

Incidence of organ failure in patients with severe acute pancreatitis
por: Lapauw, S, et al.
Publicado: (2003)

Correlation between changes in mediators and number of dysfunctional organs in sepsis-associated multiple organ dysfunction syndrome (MODS)
por: Taniuchi, H, et al.
Publicado: (2003)

Lymphopenia, hypoprolactinemia and lymphocyte depletion in pediatric multiple organ failure
por: Felmet, K, et al.
Publicado: (2003)

A study of medical in-patients reveals a high number with organ failure
por: Lamb, FJ, et al.
Publicado: (1997)

Severity of illness, critical events, organ failure assessment and ICU outcome
por: Silva Alvaro, M, et al.
Publicado: (2000)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Is the degree of multiple organ dysfunction related to severity of capillary leakage?
por: Knotzer, H, et al.
Publicado: (2002)

Plasma nuclear matrix protein (NMP) levels in patients with multiple organ failure
por: Endo, S, et al.
Publicado: (1997)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

Evaluation of the SOFA (Sepsis-related Organ Failure Assessment) Score in 303 consecutive patients of a medical intensive care unit
por: Janssens, U, et al.
Publicado: (1999)

Reactive haemophagocytic lymphohistiocytosis: a frequent finding in immunosuppressed patients with multiple organ failure
por: Auzinger, G, et al.
Publicado: (2001)

Relationship between reactive hemophagocytic syndrome (RHS) and multiple organ system failure (MOSF)
por: Gauvin, F, et al.
Publicado: (1998)

High impact of Sepsis-related Organ Failure Assessment score on mortality prediction of patients undergoing valve replacement on the first postoperative day
por: Gomes, RV, et al.
Publicado: (2003)

Prognostics index: evaluation of Sequential Organ Failure Assessment and Multiple Organ Dysfunction Score in patients after cardiac arrest in intensive care
por: Guimarães, HP, et al.
Publicado: (2003)

Complement activation in relation to age in patients with severe sepsis
por: Marx, G, et al.
Publicado: (2002)

Steroid hormone synthesis is impaired in patients with severe sepsis
por: Angstwurm, M, et al.
Publicado: (2003)

Increased procalcitonin serum levels as predictive parameter of multiple organ failure and outcome in acute pancreatitis patients
por: Lobo, SMA, et al.
Publicado: (1999)

Prognostic value of the bone marrow in severe sepsis/septic shock
por: Milheiro, R, et al.
Publicado: (1999)

Monoethylglycinexylidide (MEGX) as an early predictor of liver dysfunction in severe sepsis
por: Esen, F, et al.
Publicado: (1997)

Nutritional parameters in patients with severe catabolism due to trauma or sepsis
por: Gallioli, G, et al.
Publicado: (1997)

Comparison of pressure-related performance data with data measured by thermodilution in heart failure and sepsis
por: Engelmann, L, et al.
Publicado: (2000)

An upper estimate of the attributable mortality and cost of severe sepsis in surgical patients
por: Linde-Zwirble, WT, et al.
Publicado: (2003)

Phagocytosis of granulocytes is decreased in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2000)

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis
por: Inthorn, D, et al.
Publicado: (1998)

The IL-10 -819T polymorphism is associated with increased susceptibility to severe sepsis
por: Wood, KA, et al.
Publicado: (2003)

Comparing the effects of dopexamine and dobutamine on splanchnic parameters in patients with severe sepsis
por: Esen, F, et al.
Publicado: (1998)

Sequential organ failure assessment in neurocritical care
por: Zygun, D, et al.
Publicado: (2003)

Multiple organ dysfuntion in ARDS
por: Dias, FS, et al.
Publicado: (2001)

Pathogenesis of organ damage during sepsis. In vitro influence of lipopolysaccharides and cytokines on the microtubular system
por: Ruβwurm, S, et al.
Publicado: (1997)

Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
por: Staubach, KH, et al.
Publicado: (1998)

Acidosis and mortality in severe sepsis and septic shock evaluated by base excess variation
por: Palma, LC, et al.
Publicado: (2003)

How well does TOKS identify patients with severe sepsis or septic shock?
por: Tanderup, Anette, et al.
Publicado: (2013)

Impact of socioeconomic status on mortality and morbidity in patients with severe sepsis and septic shock
por: Schnegelsberg, Amal, et al.
Publicado: (2015)

Correlation of cytokine levels with clinical markers of organ hypoperfusion in sepsis syndrome patients (INTERSEPT trial)
por: Lemm, G, et al.
Publicado: (1997)

Cost-effectiveness of early goal-directed therapy in the treatment of severe sepsis and septic shock
por: Huang, DT, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_6nc40jngdc72krvdkadvbvroge